Paliperidone
FDA Approved: * August 3, 2015Pharm Company: * ACTAVIS LABS FL INC
Category: Antipsychotic
Paliperidone, sold under the trade name Invega among others, is an atypical antipsychotic. It is mainly used to treat schizophrenia and schizoaffective disorder. It is marketed by Janssen Pharmaceuticals. An extended release formulation is available that uses the OROS extended release system to allow for once-daily dosing. Paliperidone palmitate is a long-acting injectable formulation of paliperidone palmitoyl ester. It is on the World Health Organization's List of Essential Medicines.... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.3 Discussions
Dosage List
Paliperidone 1.5 mg Oral Tablet, Film Coated, Extended Release
NDC: 0378-3978
Labeler:
Mylan Pharmaceuticals Inc.
Paliperidone 3 mg Oral Tablet, Film Coated, Extended Release
NDC: 0378-3979
Labeler:
Mylan Pharmaceuticals Inc.
Paliperidone 6 mg Oral Tablet, Film Coated, Extended Release
NDC: 0378-3980
Labeler:
Mylan Pharmaceuticals Inc.
Paliperidone 9 mg Oral Tablet, Film Coated, Extended Release
NDC: 0378-3981
Labeler:
Mylan Pharmaceuticals Inc.
Paliperidone 1.5 mg Oral Tablet, Film Coated, Extended Release
NDC: 0591-3692
Labeler:
Actavis Pharma, Inc.
Paliperidone 3 mg Oral Tablet, Film Coated, Extended Release
NDC: 0591-3693
Labeler:
Actavis Pharma, Inc.
Paliperidone 6 mg Oral Tablet, Film Coated, Extended Release
NDC: 0591-3694
Labeler:
Actavis Pharma, Inc.
Paliperidone 9 mg Oral Tablet, Film Coated, Extended Release
NDC: 0591-3695
Labeler:
Actavis Pharma, Inc.
Related Brands
Drugs with the same active ingredientsPopular Topics
Paliperidone Palmitate
2 REPLIES
Does IM injection Paliperidone Palmitate (Invega Sustenna) lose potency or become unsafe if it has been stored in far ab...